Lanreotide acetate
Lanreotide acetate is a synthetic somatostatin analog employed in research for its antineoplastic properties. It is widely used in studies of neuroendocrine tumors, such as carcinoid syndrome, to investigate receptor-mediated inhibition of hormone secretion and cell proliferation in both in vitro and in vivo models.
Product Specifications
Product Name Alternative
108736-35-2, 108736-35-2 free base, adenoma, BIM23014, BIM-23014, BIM23014 Acetate, BIM-23014 Acetate, BIM 23014, BIM 23014 (acetate), BIM 23014 acetate, BIM 23014 Acetate, apoptosis, Inhibitor, Lanreotide, Lanreotide acetate, Lanreotide Acetate, Lanreotide acetate (108736-35-2 free base), hormone, GH-secreting, GH3 cells, inhibit, tumor, pituitary
Field of Research
Pharmacology & Drug Discovery
Purity
99.85% (May vary between batches)
Solubility
DMSO:125 mg/mL (108.1 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (1.73 mM)
Molecular Weight
1156.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2115982-01 0.1 mL
HRP-Linked Polyclonal Antibody to Frizzled Homolog 10 (FZD10)
Sign In for Pricing
View Details MBS2115982-02 0.2 mL
HRP-Linked Polyclonal Antibody to Frizzled Homolog 10 (FZD10)
Sign In for Pricing
View Details